Clinical Trials Arena on MSN
Speech biomarkers offer new lease of life to patient experience and trial retention
According to Adalyon’s CEO, Ulrik Zeuthen, speech-based biomarkers can be used across several applications to optimise trial operations and improve patient satisfaction.
Cancer biology is a rapidly evolving field, with pathology and biomarker research at the forefront of innovations in ...
Researchers from the National Institutes of Health have discovered a biomarker in the DNA of five different types of cancerous tumors, as well as evidence that the genetic signature may be present in ...
ATPase inhibitory factor 1 (IF1) has been hypothesized as a biomarker of mitochondrial energy metabolism in which higher levels are associated with protection against insulin resistance. Among people ...
Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...
We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 19 Table 1 summarizes the eligibility criteria. Study design Quantitative (interventional or ...
"This study aimed to identify bioimaging biomarkers that could possibly correlate with amyloid patients. If a careful medical history is taken from the patient, the right multimodal imaging is ...
The phase 2a trial showed GR-0621 met primary and secondary endpoints, demonstrating safety and efficacy over 12 weeks. Phase 2a data show oral GRI-0621 was safe and improved immune and fibrosis ...
The "Cancer Biomarkers Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Biomarker, Type of Cancer and Key Geographical Regions" report has been added to ...
Data are lacking about the relationship between type 2 diabetes and the risks of heart failure (HF) among people with elevated cardiac biomarkers. This information is particularly scant among Black ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results